rs1060500996
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_024685.4(BBS10):c.257_261delTTATT(p.Phe86TyrfsTer8) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_024685.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Bardet-Biedl syndrome Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. A different truncation downstream of this variant (p.Cys91Leufs*5) has been determined to be pathogenic (PMID: 16582908, 20805367, 24746959, 24400638). This suggests that deletion of this region of the BBS10 protein is causative of disease. While this particular variant has not been reported in the literature, loss-of-function variants in BBS10 are known to be pathogenic (PMID: 16582908). This sequence change deletes 5 nucleotides from exon 2 of the BBS10 mRNA (c.257_261delTTATT), causing a frameshift at codon 86. This creates a premature translational stop signal in the last exon of the BBS10 mRNA (p.Phe86Tyrfs*8). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt and delete the last 638 amino acids of the BBS10 protein. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at